Product Name:
Fgr-pY208+pY209
Product Number:
ab-pk638
Target Full Name: Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene
Target Alias: C-Fgr; Fgr protein; Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene; Kinase Fgr; P55c-fgr; P55-Fgr; p58c-fgr; Proto-oncogene tyrosine-protein kinase Fgr; SRC2; FLJ43153; MGC75096; Q5TGY6; ENSG00000000938
Product Type Specific: Protein kinase phosphosite-specific antibody
Antibody Code: PK638
Antibody Target Type: Phosphosite-specific
Antibody Phosphosite: Y208+Y209
Protein UniProt: P09769
Protein SigNET: P09769
Antibody Type: Polyclonal
Antibody Host Species: Rabbit
Antibody Immunogen Source: Human Fgr sequence peptide Cat. No.: PE-04AMH80
Antibody Immunogen Sequence: MGG(pY)(pY)ITT(bA)C
Antibody Immunogen Description: Corresponds to amino acid residues M205 to T212; In the SH2 domain. Two of This is the major in vivo phosphorylation sites in Fgr.
Production Method: Corresponds to amino acid residues M205 to T212; In the SH2 domain. Two of This is the major in vivo phosphorylation sites in Fgr.
Antibody Modification: Protein kinase phosphosite-specific antibody
Antibody Concentration: 1 mg/ml
Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol
Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.
Product Use: Western blotting | Antibody microarray
Antibody Dilution Recommended: 2 µg/ml for immunoblotting
Antibody Potency: Medium immunoreactivity of a target-sized protein by Western blotting in HeLa cells following treatment with phenylarsine oxide (PAO) .
Antibody Species Reactivity: Human
Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 55-63 kDa.
Antibody Specificity: Medium-high
Antibody Cross Reactivity: Some cross-reactivities in A549 cells including EGF increase in 50 kDa protein, which might be target. Clean in HeLa, except phenylarsine oxide (PAO) increases 54 kDa protein, which may be target. Fairly clean in HepG2, Jurkat and T98G cells, except that in Jurkat cells, phenylarsine PAO treatment increased 15 kDa protein detection and decreased 75 kDa protein immunoreactivity.
Related Product 1: Fgr-pY208+pY209 blocking peptide
Related Product 2: Fgr-ANT pan-specific antibody (Cat. No.: AB-NK268-1)
Related Product 3: Fgr-pY412 phosphosite-specific antibody (Cat. No.: AB-PK639)
Scientific Background: Fgr is a protein-tyrosine kinase of the TK group and Src family. It is a non-receptor kinase that transmits signals from cell surface receptors and regulates immune responses. In addition, it functions as positive regulator of cell migration and regulates cytoskeleton reorganization. Fgr appears to be an oncoprotein (OP). A Y523F mutation in Fgr is associated with strongly increased catalytic activity, which can be oncogenic and promote abnormal cell proliferation. Fgr oncogene mRNA was found to be induced in B lymphocytes by Epstein-Barr virus infection.
